Elena Caceres | Senior Scientist, Machine Learning
Nurix Therapeutics

Elena Caceres, PhD, is Senior Machine Learning Scientist at Nurix Therapeutics, a clinical-stage biotech at the forefront of targeted protein degradation for cancer and autoimmune diseases. At Nurix, Dr. Caceres leads the development of DEL-FM, a state-of-the-art machine learning platform built on Nurix’s proprietary DNA-encoded library data. This innovative approach accelerates lead optimization and transforms how small molecule–protein interactions are predicted. Nurix’s AI-integrated pipeline drives rapid discovery and development of next-generation protein degraders, including Bexobrutideg (NX-5948) for B-cell malignancies and a broad array of oncology and immunology programs, advanced through strategic partnerships. Dr. Caceres holds a PhD in Biological and Medical Informatics from UCSF and brings deep expertise in AI, cheminformatics, and drug discovery. Her work advances Nurix’s mission to deliver breakthrough therapeutics to patients with urgent medical needs.